Calero M, Tokuda T, Rostagno A, Kumar A, Zlokovic B, Frangione B, Ghiso J
Department of Pathology, New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA.
Biochem J. 1999 Dec 1;344 Pt 2(Pt 2):375-83.
Apolipoprotein J (apoJ, clusterin) is a multifunctional protein normally associated with lipids in plasma and cerebrospinal fluid, and secreted as lipoparticles by hepatocytes and astrocytes. To investigate whether the structural and functional properties of apoJ are modulated upon binding to lipids, we prepared apoJ high-density lipoprotein (HDL)-like particles employing either synthetic or plasma HDL-derived lipids. The majority of the resulting lipoparticles contained one molecule of apoJ per particle and exhibited the same alpha2 electrophoretic mobility characteristic of apoJ-containing plasma HDL. Particle size seemed to be dependent on the presence of cholesterol in the lipid mixture and ranged from diameters of 10 nm in the presence of cholesterol to 20 nm in the absence of cholesterol. CD analysis and Fourier-transform infrared spectroscopy revealed similar changes in the apoJ secondary structure induced by its incorporation into lipoparticles, namely a decrease in alpha-helix content and an increase in beta-turn structures. Two functional assays, the binding interaction with Alzheimer's amyloid beta peptides and the inhibitory activity of the complement membrane-attack complex, did not detect any changes in apoJ activity following its lipidation (P>0.05). On the contrary, the binding affinity to the cellular receptor megalin was enhanced significantly (P<0.01) after the association with lipids; the K(d) value decreased from 78.8+/-10.7 nM for the delipidated form to 37. 0+/-7.3 nM for apoJ-HDL. Although it is not known whether the structural changes observed are directly responsible for the higher receptor-binding affinity, the data suggest that the complement inhibition and amyloid beta-binding motifs are located in areas of the molecule different from those involved in the apoJ-megalin interaction.
载脂蛋白J(apoJ,簇集蛋白)是一种多功能蛋白,通常与血浆和脑脊液中的脂质相关,并由肝细胞和星形胶质细胞作为脂蛋白颗粒分泌。为了研究apoJ的结构和功能特性在与脂质结合后是否受到调节,我们使用合成脂质或血浆高密度脂蛋白(HDL)衍生的脂质制备了apoJ高密度脂蛋白样颗粒。大多数生成的脂蛋白颗粒每个颗粒含有一个apoJ分子,并表现出与含apoJ的血浆HDL相同的α2电泳迁移率特征。颗粒大小似乎取决于脂质混合物中胆固醇的存在,直径范围从存在胆固醇时的10纳米到不存在胆固醇时的20纳米。圆二色性分析和傅里叶变换红外光谱显示,apoJ掺入脂蛋白颗粒后其二级结构发生了类似变化,即α-螺旋含量减少,β-转角结构增加。两项功能测定,即与阿尔茨海默病淀粉样β肽的结合相互作用和补体膜攻击复合物的抑制活性,在apoJ脂质化后未检测到其活性有任何变化(P>0.05)。相反,与脂质结合后,对细胞受体巨膜蛋白的结合亲和力显著增强(P<0.01);解离常数(K(d))值从脱脂形式的78.8±10.7 nM降至apoJ-HDL的37.0±7.3 nM。虽然尚不清楚观察到的结构变化是否直接导致了更高的受体结合亲和力,但数据表明补体抑制和淀粉样β结合基序位于分子中与apoJ-巨膜蛋白相互作用不同的区域。